Pharmaceutical giants simultaneously announced work on developing a vaccine that will prevent complications from the dangerous new omicron coronavirus strain,
Pfizer & BioNTech are ready to adapt their existing coronavirus vaccine. The company expects comprehensive lab test data no later than two weeks to confirm that the strain requires adjustments to vaccine production technology.
Johnson & Johnson is also testing a vaccine against the new Omicron strain and AstraZeneca is already conducting research at the sites of the first Omicron outbreaks, CNBC reported.
Moderna said Friday that the combination of mutations in the new strain has a significant potential risk for accelerating the weakening of natural and vaccine-induced immunity.
The company explained that the only way to somehow protect oneself from the risks of omicron is currently the booster dose. The Moderna study will involve volunteers who received the third dose of the vaccine.